ChemRxiv
These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
1/1
4 files

Defects Formation and Amorphization of Zn-MOF-74 Crystals by Post-Synthetic Interactions with Bidentate Adsorbates

preprint
submitted on 31.10.2020, 05:11 and posted on 02.11.2020, 10:18 by Jonathan B Lefton, Kyle B Pekar, Uroob Haris, Mary E. Zick, Phillip J. Milner, Alexander Lippert, Ljupco Pejov, Tomce Runcevski
The controlled introduction of defects into MOFs is a powerful strategy to induce new physiochemical properties and improve their performance for target applications. Herein, we present a new strategy for defect formation and amorphization.

History

Email Address of Submitting Author

truncevski@smu.edu

Institution

Southern Methodist University

Country

USA

ORCID For Submitting Author

0000-0003-0886-8464

Declaration of Conflict of Interest

A.R.L. discloses a financial stake in BioLum Sciences, LLC, a company developing medical devices. P.J.M is listed as an inventor on several provisional patents involving functionalized variants of MOF-74.

Exports

Logo branding

Exports